Microbe- and danger-induced inflammation

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 127-133

  Broggi, Achille ^a   Granucci, Francesca ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Danger; HMGB1; Infections; Inflammasome; Inflammation; TLRs

Indexed keywords

CD24 ANTIGEN; CRYOPYRIN; HIGH MOBILITY GROUP B1 PROTEIN; INFLAMMASOME; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISULFIDE BOND; HEALTH HAZARD; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTERFERON PRODUCTION; MICROORGANISM; MICROTUBULE ASSEMBLY; MOLECULAR RECOGNITION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; ANIMAL; BACTERIA; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ANIMALS; BACTERIA; HMGB1 PROTEIN; HUMANS; INFLAMMASOMES; INFLAMMATION; RECEPTORS, PATTERN RECOGNITION; TOLL-LIKE RECEPTORS;

EID: 84912051449     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.06.037     Document Type: Article

References (64)

1. Anderson J., Mueller J., Misaghi A., Anderson S., Sivagnanam M., Kolodner R., Hoffman H. Initial description of the human NLRP3 promoter. Gene Immun. 2008, 9:721-726.
2. Anthony B., Link D. Regulation of hematopoietic stem cells by bone marrow stromal cells. Trends Immunol. 2014, 35:32-37.
3. Banchereau J., Steinman R. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
4. Barbara C., Assaf W., Francesca Di F., Francesco M.M., Elisa C., Riccardo L.R., Lorna G., Dilair B., Grazisa R., Paolo G., Massimiliano P., Tiziana B., Jiannis R., Nir F., Giorgio C., Marco E.B., Alessandra A., Peter B.B. Substantial Histone reduction modulates genomewide nucleosomal occupancy and global transcriptional output. PLoS Biol. 2011, 9.
5. Bauernfeind F., Horvath G., Stutz A., Alnemri E., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B., Fitzgerald K., Hornung V., Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol.V 183 2009, 787-791.
6. Bianchi M. HMGB1 loves company. J. Leukoc. Biol. 2009, 86:573-576.
7. Billingham R., Brent L., Medawar P. Actively acquired tolerance of foreign cells. Nature 1953, 172:603-606.
8. Blander J., Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006, 440:808-812.
9. Brown G., Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001, 413:36-37.
10. Burnet S.F.M. The clonal selection theory of acquired immunity 1959, 3. Vanderbilt University Press, Nashville.
11. Chen G., Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
12. Chen G.-Y., Tang J., Zheng P., Liu Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 2009, 323:1722-1725.
13. Duewell P., Kono H., Rayner K., Sirois C., Vladimer G., Bauernfeind F., Abela G., Franchi L., Nuñez G., Schnurr M., Espevik T., Lien E., Fitzgerald K., Rock K., Moore K., Wright S., Hornung V., Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
14. Fiuza C. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2002, 101.
15. Franchi L., Eigenbrod T., Núñez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J. Immunol. 2009, 183:792-796.
16. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 1999, 5:1249-1255.
17. Goodridge H., Simmons R., Underhill D. Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J. Immunol. 2007, 178:3107-3115.
18. Hornung V., Bauernfeind F., Halle A., Samstad E., Kono H., Rock K., Fitzgerald K., Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008, 9:847-856.
19. Hornung V., Latz E. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 2010, 40:620-623.
20. Ivanov S., Dragoi A.-M., Wang X., Dallacosta C., Louten J., Musco G., Sitia G., Yap G., Wan Y., Biron C., Bianchi M., Wang H., Chu W.-M. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007, 110:1970-1981.
21. Janeway C. Approaching the asymptote?. Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54(Pt1):1-13.
22. Janeway C. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 1992, 13:11-16.
23. Jiang W., Pisetsky D.S. The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide. J. Immunol. 2006, 177:3337-3343.
24. Kahlenberg J., Lundberg K., Kertesy S., Qu Y., Dubyak G. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J. Immunol. 2005, 175:7611-7622.
25. Kawai T., Akira S. TLR signaling. Cell Death Differ. 2006, 13:816-825.
26. Kayagaki N., Warming S., Lamkanfi M., Vande Walle L., Louie S., Dong J., Newton K., Qu Y., Liu J., Heldens S., Zhang J., Lee W.P., Roose-Girma M., Dixit V.M. Non-canonical inflammasome activation targets caspase-11. Nature 2011, 479:117-121.
27. Kazama H., Ricci J.-E., Herndon J., Hoppe G., Green D., Ferguson T. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008, 29:21-32.
28. Kew R., Penzo M., Habiel D., Marcu K. The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1. J. Immunol. 2012, 188:2380-2386.
29. Kim S., Kim S., Pribis J., Lotze M., Mollen K., Shapiro R., Loughran P., Scott M., Billiar T. Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14. Mol. Med. 2013, 19:88-98.
30. Kim T.S., Gorski S.A., Hahn S., Murphy K.M., Braciale T.J. Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism. Immunity 2014, 40:400-413.
31. Kono H., Chen C.-J., Ontiveros F., Rock K. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J. Clin. Investig. 2010, 120:1939-1949.
32. Lafferty K., Cunningham A. A new analysis of allogeneic interactions. Aust. J. Exp. Biol. Med. Sci. 1975, 53:27-42.
33. Lamkanfi M., Sarkar A., Vande Walle L., Vitari A.C., Amer A.O., Wewers M.D., Tracey K.J., Kanneganti T.-D.D., Dixit V.M. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J. Immunol. 2010, 185:4385-4392.
34. Lemaitre B., Nicolas E., Michaut L., Reichhart J., Hoffmann J. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
35. Lu B., Antoine D.J., Kwan K., Lundbäck P., Wähämaa H., Schierbeck H., Robinson M., Van Zoelen M.A., Yang H., Li J., Erlandsson-Harris H., Chavan S.S., Wang H., Andersson U., Tracey K.J. JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc. Natl. Acad. Sci. U.S.A. 2014.
36. Lu B., Nakamura T., Inouye K., Li J., Tang Y., Lundbäck P., Valdes-Ferrer S.I., Olofsson P.S., Kalb T., Roth J., Zou Y., Erlandsson-Harris H., Yang H., Ting J.P., Wang H., Andersson U., Antoine D.J., Chavan S.S., Hotamisligil G.S., Tracey K.J. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 2012, 488:670-674.
37. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994, 12:991-1045.
38. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009, 30:766-775.
39. Medzhitov R., Preston-Hurlburt P., Janeway C. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
40. Misawa T., Takahama M., Kozaki T., Lee H., Zou J., Saitoh T., Akira S. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol. 2013, 14:454-460.
41. Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S., Nagase T., Seki N., Ishikawa K., Tabata S. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res. 1994, 1:27-35.
42. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., Cossu G., Bianchi M. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 2004, 164:441-449.
43. Paola S., Tom M., Marco E.B. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418.
44. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
45. Peng G., Guo Z., Kiniwa Y., Voo K., Peng W., Fu T., Wang D., Li Y., Wang H., Wang R.-F. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005, 309:1380-1384.
46. Poltorak A. Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: mutations in Tlr4 Gene. Science 1998, 282.
47. Rendon-Mitchell B., Ochani M., Li J., Han J., Wang H., Yang H., Susarla S., Czura C., Mitchell R.A., Chen G., Sama A.E., Tracey K.J., Wang H. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J. Immunol. 2003, 170:3890-3897.
48. Rovere-Querini P., Capobianco A., Scaffidi P., Valentinis B., Catalanotti F., Giazzon M., Dumitriu I., Müller S., Iannacone M., Traversari C., Bianchi M., Manfredi A. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004, 5:825-830.
49. Schenten D., Nish S., Yu S., Yan X., Lee H., Brodsky I., Pasman L., Yordy B., Wunderlich F., Brüning J., Zhao H., Medzhitov R. Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells. Immunity 2014, 40:78-90.
50. Schiraldi M., Raucci A., Muñoz L., Livoti E., Celona B., Venereau E., Apuzzo T., De Marchis F., Pedotti M., Bachi A., Thelen M., Varani L., Mellado M., Proudfoot A., Bianchi M., Uguccioni M. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J. Exp. Med. 2012, 209:551-563.
51. Schnare M., Barton G., Holt A., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2001, 2:947-950.
52. Shi Y., Zheng W., Rock K. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:14590-14595.
53. Strowig T., Henao-Mejia J., Elinav E., Flavell R. Inflammasomes in health and disease. Nature 2012, 481:278-286.
54. Urbonaviciute V., Fürnrohr B., Meister S., Munoz L., Heyder P., De Marchis F., Bianchi M., Kirschning C., Wagner H., Manfredi A., Kalden J., Schett G., Rovere-Querini P., Herrmann M., Voll R. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 2008, 205:3007-3018.
55. Venereau E., Casalgrandi M., Schiraldi M., Antoine D.J., Cattaneo A., Marchis F.D., Liu J., Antonelli A., Preti A., Raeli L., Shams S.S., Yang H., Varani L., Andersson U., Tracey K.J., Bachi A., Uguccioni M., Bianchi M.E. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J. Exp. Med. 2012, 209.
56. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
57. Wuest S., Edwan J., Martin J., Han S., Perry J., Cartagena C., Matsuura E., Maric D., Waldmann T., Bielekova B. A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nat. Med. 2011, 17:604-609.
58. Yang D., Chen Q., Yang H., Tracey K., Bustin M., Oppenheim J. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 2007, 81:59-66.
59. Yang H., Hreggvidsdottir H., Palmblad K., Wang H., Ochani M., Li J., Lu B., Chavan S., Rosas-Ballina M., Al-Abed Y., Akira S., Bierhaus A., Erlandsson-Harris H., Andersson U., Tracey K. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11942-11947.
60. Yang Y., Huang C.-T., Huang X., Pardoll D. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat. Immunol. 2004, 5:508-515.
61. Youn J., Oh Y., Kim E., Choi J., Shin J.-S. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J. Immunol. 2008, 180:5067-5074.
62. Zanoni I., Ostuni R., Barresi S., Di Gioia M., Broggi A., Costa B., Marzi R., Granucci F. CD14 and NFAT mediate lipopolysaccharide-induced skin edema formation in mice. J. Clini. Investig. 2012, 122:1747-1757.
63. Zanoni I., Ostuni R., Capuano G., Collini M., Caccia M., Ronchi A., Rocchetti M., Mingozzi F., Foti M., Chirico G., Costa B., Zaza A., Ricciardi-Castagnoli P., Granucci F. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 2009, 460:264-268.
64. Zanoni I., Ostuni R., Marek L., Barresi S., Barbalat R., Barton G., Granucci F., Kagan J. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011, 147:868-880.